A SARS-CoV-2 variant of concern triggers Fc effector function with increased cross-reactivity

Simone I. Richardson; Nelia P. Manamela; Boitumelo M. Motsoeneng; Haajira Kaldine; Frances Ayres; Zanele Makhado; Mathilda Mennen; Sango Skelem; Noleen Williams; Nancy J. Sullivan; John Misasi; Glenda G. Gray; Linda-Gail Bekker; Veronica Ueckermann; Theresa M. Rossouw; Michael T. Boswell; Ntobeko A. B. Ntusi; Wendy A. Burgers; Penny L. Moore

doi:10.1101/2021.11.05.21265853

A SARS-CoV-2 variant of concern triggers Fc effector function with increased cross-reactivity

View ORCID ProfileSimone I. Richardson, View ORCID ProfileNelia P. Manamela, View ORCID ProfileBoitumelo M. Motsoeneng, View ORCID ProfileHaajira Kaldine, View ORCID ProfileFrances Ayres, Zanele Makhado, Mathilda Mennen, Sango Skelem, Noleen Williams, View ORCID ProfileNancy J. Sullivan, View ORCID ProfileJohn Misasi, View ORCID ProfileGlenda G. Gray, View ORCID ProfileLinda-Gail Bekker, View ORCID ProfileVeronica Ueckermann, View ORCID ProfileTheresa M. Rossouw, View ORCID ProfileMichael T. Boswell, View ORCID ProfileNtobeko A. B. Ntusi, View ORCID ProfileWendy A. Burgers, View ORCID ProfilePenny L. Moore

doi: https://doi.org/10.1101/2021.11.05.21265853

Simone I. Richardson

1National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa

2MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Simone I. Richardson

Nelia P. Manamela

1National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa

2MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Nelia P. Manamela

Boitumelo M. Motsoeneng

1National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa

2MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Boitumelo M. Motsoeneng

Haajira Kaldine

1National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa

2MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Haajira Kaldine

Frances Ayres

1National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa

2MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Frances Ayres

Zanele Makhado

1National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa

2MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mathilda Mennen

9Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sango Skelem

9Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Noleen Williams

9Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nancy J. Sullivan

3Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Nancy J. Sullivan

John Misasi

3Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for John Misasi

Glenda G. Gray

4The South African Medical Research Council, Tygerberg, South Africa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Glenda G. Gray

Linda-Gail Bekker

5The Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Linda-Gail Bekker

Veronica Ueckermann

6Division for Infectious Diseases, Department of Internal Medicine, Steve Biko Academic Hospital and University of Pretoria, Pretoria, South Africa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Veronica Ueckermann

Theresa M. Rossouw

7Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Theresa M. Rossouw

Michael T. Boswell

6Division for Infectious Diseases, Department of Internal Medicine, Steve Biko Academic Hospital and University of Pretoria, Pretoria, South Africa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Michael T. Boswell

Ntobeko A. B. Ntusi

8Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa

9Cape Heart Institute, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa

10Department of Medicine, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa

12Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Cape Town, South Africa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Ntobeko A. B. Ntusi

Wendy A. Burgers

8Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa

11Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa

12Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Cape Town, South Africa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Wendy A. Burgers

Penny L. Moore

1National Institute for Communicable Diseases of the National Health Laboratory Services, Johannesburg, South Africa

2MRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa

8Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa

13Centre for the AIDS Programme of Research in South Africa, Durban, South Africa

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Penny L. Moore
For correspondence: pennym@nicd.ac.za

Abstract
Full Text
Info/History
Metrics
Supplementary material
Data/Code
Preview PDF

Data Availability

All data produced in the present study are available upon reasonable request to the authors

View the discussion thread.

PreviousNext

Posted November 05, 2021.

Download PDF

Supplementary Material

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following A SARS-CoV-2 variant of concern triggers Fc effector function with increased cross-reactivity

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

A SARS-CoV-2 variant of concern triggers Fc effector function with increased cross-reactivity

Simone I. Richardson, Nelia P. Manamela, Boitumelo M. Motsoeneng, Haajira Kaldine, Frances Ayres, Zanele Makhado, Mathilda Mennen, Sango Skelem, Noleen Williams, Nancy J. Sullivan, John Misasi, Glenda G. Gray, Linda-Gail Bekker, Veronica Ueckermann, Theresa M. Rossouw, Michael T. Boswell, Ntobeko A. B. Ntusi, Wendy A. Burgers, Penny L. Moore

medRxiv 2021.11.05.21265853; doi: https://doi.org/10.1101/2021.11.05.21265853

Share This Article: